Platinum-Montaur Life Sciences, LLC's Net Worth
-$465 Thousand
Who is Platinum-Montaur Life Sciences, LLC?
Platinum-Montaur Life Sciences, LLC does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include NAVIDEA BIOPHARMACEUTICALS, INC., DAIS ANALYTIC CORP, and Echo Therapeutics, Inc..
SEC CIK
Platinum-Montaur Life Sciences, LLC's CIK is 0001404598
Past Insider Trading and Trends
2009 was Platinum-Montaur Life Sciences, LLC's most active year for acquiring shares with 2 total transactions. Platinum-Montaur Life Sciences, LLC's most active month to acquire stocks was the month of February. 2009 was Platinum-Montaur Life Sciences, LLC's most active year for disposing of shares, totalling 6 transactions. Platinum-Montaur Life Sciences, LLC's most active month to dispose stocks was the month of August. 2009 saw Platinum-Montaur Life Sciences, LLC paying a total of $914,698.00 for 4,323,740 shares, this is the most they've acquired in one year. In 2009 Platinum-Montaur Life Sciences, LLC cashed out on 686,536 shares for a total of $252,947.54, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
NAVIDEA BIOPHARMACEUTICALS, INC. (NAVB) Snapshot price: $0.0251
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
DAIS ANALYTIC CORP (DLYT) Snapshot price: $0.020673
InvestorPlatinum-Montaur Life Sciences, LLC owns 3,238,204 units of Common Stock which is worth $66,943.39. In the year 2009 Platinum-Montaur Life Sciences, LLC filed a total of 3 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
∞
| 3.24M |
$0.87 | $532,000.46 | 3.24M |
Mar 12 - Sep 25
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Echo Therapeutics, Inc. No price found
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4/A
| -65.68% | -1.50M |
—
|
—
| 783.88K |
Dec 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 18
| |||
Form 4
| +10.73% | 65.74K |
$2.20 | $144,625.80 | 678.45K |
Jun 27 - Jun 30
| |||
Form 4
| +2.91% | 17.3K |
$2.20 | $38,060.00 | 612.71K |
Jun 25 - Jun 26
| |||
Form 4
| +2.93% | 16.96K |
$2.20 | $37,307.60 | 595.41K |
Jun 20 - Jun 24
| |||
Form 4
| +6.84% | 69.57K |
$2.75 | $191,314.75 | 1.09M |
Dec 10
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||